Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease
This study has been completed.
Study NCT00118976 Information provided by Steno Diabetes Center
First Received: July 1, 2005 Last Updated: November 22, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type I
Diabetic Nephropathy
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 1
Diabetic Nephropathies
Kidney Diseases
More general conditions related to this trial
Autoimmune Diseases
Diabetes Complications
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Urologic Diseases
Interventions listed in this trial
Lisinopril
Additional drug interventions recognized in this trial
Angiotensin-Converting Enzyme Inhibitors
More general drug interventions related to this trial
Antihypertensive Agents
Cardiotonic Agents
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Steno Diabetes Center
Back to top of Main Content
